CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,009,000 | +0.1% | 83,607 | +4.1% | 0.40% | -15.2% |
| Q4 2018 | $1,008,000 | +3.0% | 80,300 | +21.7% | 0.47% | +49.1% |
| Q3 2018 | $979,000 | +12.8% | 66,000 | +28.0% | 0.32% | -2.2% |
| Q2 2018 | $868,000 | -23.5% | 51,557 | +4.0% | 0.32% | -30.6% |
| Q1 2018 | $1,135,000 | -11.5% | 49,557 | 0.0% | 0.47% | -8.2% |
| Q4 2017 | $1,282,000 | +93.1% | 49,557 | +10.1% | 0.51% | +79.6% |
| Q3 2017 | $664,000 | – | 45,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |